In the INSPECT project, five Thüringen partners are working on microelectronic systems for the early detection of cancer. Photograph: IMMS.
In the INSPECT project, five Thüringen partners are working on microelectronic systems for the early detection of cancer. Photograph: IMMS.

INSPECT

Mikroelektronische Diagnostikplattformen für die personalisierte Krebsforschung und Mikro-Bioreaktoren

Personalised recognition and therapy of cancer thanks to smart microelectronic diagnostic systems

In the INSPECT research project IMMS is developing systems for the early recognition of breast, cervical, prostate and lung cancers using semiconductor chips as well as immunological and cell-based biotechnological methods. IMMS is working on an interdisciplinary interface between biology and microelectronics for signal processing. In addition, further concepts for microelectronic-based point-of-care diagnostics and for personalized cancer immunotherapies are being investigated.

IMMS is currently testing the first prototypes of the miniaturized diagnostic devices. The research partners iba Institut für Bioprozess- und Analysenmesstechnik e.V. Heiligenstadt, Senova Gesellschaft für Biowissenschaft und Technik mbH Weimar, CDA GmbH Suhl and X-FAB Semiconductor Foundries AG Erfurt are contributing to the novel solutions. IMMS is coordinating the consortium.

  • Funding

    The INSPECT project was funded by the “Land” of Thüringen and the European Union under the reference 2015 FE 9159.

Duration

2016-2019

Reference

2015 FE 9159